Efficacy and safety of cefdinir in the treatment of maxillary sinusitis

European Archives of Oto-Rhino-Laryngology

Volumn 257, Issue 3, 2000, Pages 140-148

  Steurer, M ^a   Schenk, P ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibiotic related complications; Antibiotics; Sinus infections; lactamase producing bacteria

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFDINIR;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BLOOD DISEASE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUSITIS; METABOLIC DISORDER; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SINGLE BLIND PROCEDURE; SYMPTOM; URTICARIA; VAGINITIS;

EID: 0033995459     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004050050211     Document Type: Article

References (24)

1. Berg O, Bergstedt H, Lind MG, Carenfelt C, Perols O (1981) Discrimination of purulent from nonpurulent maxillary sinusitis. Clinical and radiographic diagnosis. Ann Otol 90:297-301
2. Camacho AE, Cobo R, Otte J, et al (1992) Clinical comparison of cefuroximeaxetil and amoxicillin/clavulanate in the treatment of acute bacterial maxillary sinusitis. Am J Med 93: 271-276
3. Carenfelt C, Melen I, Ödkvist E, Olsson O, Prellner K, Rudbald S, Savolainen S, Skaftason S, Sorri M, Synnerstad B (1990) Treatment of sinus empyema in adults; a coordinated nordic multicenter trial of cefexime versus cefaclor. Acta Otolaryngol (Stockh) 110:128-135
4. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS (1992) Evaluation of new anti-infective drugs for treatment of respiratory tract infections. Clin Infect Dis 15 [Suppl 1]:S62-S88
5. Conover WJ (1980) Practical nonparametric statistics, 2nd edn. Wiley, New York
6. Dabernat H, Delmas C, Lareng MB (1986) Prevalence of antimicrobial resistance among Haemophilus influenzae isolated in France: a collaborative study. Pathol Biol 34:372-378.
7. Forsgren A, Walder M (1994) Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 102: 227-235
8. Köhler W, Schenk P (1995) Cephalosporinbehandlung der Sinusitis maxillaris. Laryngo-Rhino-Otol 74:355-360
9. Lapointe JR, Beyeler S (1985) Susceptibility of 114 clinically significant Haemophilus influenzae strains to ampicillin, chloramphenicol, rifampicin, erythromycin, 2nd and 3rd order generation cephalosporins. Can J Publ Health 76:25-29
10. Marks MI (1984) Haemophilus influenzae infections. Clin Pediatr 23:535-541
11. Medical Officer's Review of Clarithromycine (1991) NDA 50-622, pp 115-185
12. Medical Officer's Review of Loracarbef (1991) NDA 50-667 and NDA 50-668, pp 313-356
13. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically (1990) National Committee for Clinical Laboratory Standards, NCCLS Document no. M7-A2: pp 10-12; Vilanova, Pennsylvania
14. Mine Y, Kamimamura T, Watanabe Y, et al (1988) In vitro antibacterial activity of FK 482, a new orally active cephalosporine. J Antibiotics 1873-1887
15. Neu HC, Gita S, Nai-Xun C (1989) Comparative in vitro activity and β-lactamase stability of FK482, a new cephalosporin. Chemotherapy 37:1795-1800
16. Nord CE (1988) Efficacy of penicillamin treatment in purulent maxillary sinusitis. Infection 16:209-214
17. Nord CE (1995) The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis. Clin Infect Dis 20:1512-1524
18. Norrby SR (1992) Future trends in antibiotic therapy. Scand J Infect Dis [Suppl] 83:41-45
19. Sakamoto H, Hirose T, Nakamoto S (1988) Pharmacokinetics of FK-482 a new orally active cephalosporin. J Antibiotics 41:1896-1905
20. Schito GC, Pesce A, Debbia EA (1994) Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs. Drugs 47 [Suppl 3]: 1-8
21. Searle SR (1971) Linear models: Wiley, New York
22. Shiba K, Saito A, Shimada J (1989) Clinical studies on cefdinir. Chemotherapy 37 [Suppl 2]:345-352
23. Shibl M (1992) Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Chemotherapy 38:324-329
24. Van Cauwenberge PB, Vander-Minsbrugge AM, Ingesl KJ (1993) The microbiology of acute and chronic sinusitis and otitis media. Eur Arch Otolaryngol [Suppl 1]:S3-6